...
首页> 外文期刊>Natural product research >Production of a new mucilage compound in Lepidium sativum callus by optimizing in vitro growth conditions
【24h】

Production of a new mucilage compound in Lepidium sativum callus by optimizing in vitro growth conditions

机译:通过在体外生长条件下优化肝脏愈伤组织中的一种新粘液化合物

获取原文
获取原文并翻译 | 示例

摘要

The mucilage in Lepidium sativum L. is considered a biologically active compound with diverse medicinal properties. Different explants (hypocotyls and leaf) were transferred to Murashige and Skoog (MS) medium supplemented with twelve different plant growth regulator combinations under two different incubations (light and dark). The best mucilage production from callus (36.76% g g(-1) dry weight) was obtained in the MS medium supplemented with 1 mg L-1 of 2, 4-D and 2 mg L-1 of BAP under the light condition. The mucilage produced by callus culture was nearly three times more than the mucilage yield of the seeds. The glucose, arabinose + mannose and galactose were 43.4 (mg g(-1) DW), 195.3 (mg g(-1) DW) and 86.2 (mg g(-1) DW) in the mucilage originated from seed, callus leaf and callus hypocotyl, respectively. The present study proposes an efficient method for producing large scales of mucilage with a favorable sugar aimed at food or pharmaceutical industries.
机译:Sativum L的粘膜被认为是具有不同药物性质的生物活性化合物。 不同的外植体(下胚轴和叶子)转移到Murashige和Skoog(MS)培养基,其补充有12种不同的植物生长调节剂组合在两个不同的孵化(光和黑暗)下。 从愈伤组织(36.76%g(-1)干重)中,在介质的MS培养基中获得的最佳粘液产生(36.76%G(-1)干重)在光条件下补充有1mg L-1的2,4-D和2mg L-1。 愈伤组织培养产生的粘膜比种子的粘液产率超过近三倍。 葡萄糖,阿拉伯糖+甘露糖和半乳糖是43.4(mg g(-1)dw),195.3(mg g(-1)dw)和86.2(mg g(mg g(mg(mg g(mg(mg(mg))源自种子,愈伤组织叶片 和愈伤组织缺口。 本研究提出了一种高效的方法,用于生产大规模的粘液,含有食物或制药行业的良好糖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号